ALLO vs AAPL: Which Stock is Better?
Side-by-side comparison of Allogene Therapeutics Inc and Apple Inc in 2026
ALLO
Allogene Therapeutics Inc
$2.15
AAPL
Apple Inc
$249.78
Key Metrics Comparison
| Metric | ALLO | AAPL | Winner |
|---|---|---|---|
| Market Cap | $510.14M | N/A | ALLO |
| P/E Ratio | N/A | 31.51 | AAPL |
| EPS (TTM) | $N/A | $7.90 | AAPL |
| Revenue Growth | -1.0% | 0.2% | AAPL |
| Gross Margin | 0.0% | 47.3% | AAPL |
Analyze ALLO
Full quant analysis
Analyze AAPL
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ALLO or AAPL a better investment?
Comparing ALLO and AAPL: Allogene Therapeutics Inc has a market cap of $510.14M while Apple Inc has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ALLO and AAPL?
ALLO (Allogene Therapeutics Inc) and AAPL (Apple Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ALLO or AAPL?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: ALLO or AAPL?
AAPL has higher revenue growth at 0.2% vs -1.0% for ALLO.
Which company is more profitable: ALLO or AAPL?
Apple Inc (AAPL) has higher gross margins at 47.3% compared to 0.0% for ALLO.
Which is the larger company: ALLO or AAPL?
Allogene Therapeutics Inc (ALLO) is larger with a market cap of $510.14M compared to N/A for AAPL.
Should I buy ALLO or AAPL in 2026?
Both ALLO and AAPL have investment merit. ALLO trades at $2.15 while AAPL trades at $249.78. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ALLO and AAPL stock?
Key differences: Market Cap ($510.14M vs N/A), P/E Ratio (N/A vs 31.5x), Revenue Growth (-1.0% vs 0.2%), Gross Margin (0.0% vs 47.3%).